Diagnostic significance of stimulating growth factor ST2 and N-terminal prohormone of brain natriuretic peptide NT-PROBNP in patients with ischemic heart disease in the setting of metabolic syndrome.

Unlabelled: Ischemic heart disease (IHD) is the leading cause of death and disability in many countries. The development of IHD is affected by a number of diseases, including metabolic syndrome (MS). Modern predictors of IHD include stimulating growth factor (ST2) and N-terminal prohormone of brain natriuretic peptide (NT-proBNP).